We are live on ! Find out more
VCNX

Vaccinex, Inc. Common Stock
VCNX

Delisted

VCNX was delisted on the 17th of December, 2024.

Back to rankings

12 hedge funds and large institutions have $4.26M invested in Vaccinex, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 12 → 12 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

25% less capital invested

Capital invested by funds: $5.69M → $4.26M (-$1.43M)

Holders
12
Holders Change
–
Holders Change %
0%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
3
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
OC
Oppenheimer & Co
New York
+$28.1K
2
BlackRock
BlackRock
New York
+$9.36K
3
UBS Group
UBS Group
Switzerland
+$5.46K
4
TRCT
Tower Research Capital (TRC)
New York
+$1.56K

Top Sellers

Rank Fund Capital Flow
1
MP
MSD Partners
New York
-$890K
2
Millennium Management
Millennium Management
New York
-$50.7K
3
Victory Capital Management
Victory Capital Management
Texas
-$8K
4
Northern Trust
Northern Trust
Illinois
-$2.34K

VCNX Hedge Fund Activity: Q2 2020 in Review

12 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in Vaccinex, Inc. Common Stock (VCNX) for Q2 2020, worth a combined $4.26M — down 25% from $5.69M a quarter earlier.

Fund positioning in VCNX was balanced in Q2 2020: 1 fund opened new positions, 1 closed out, 3 added to existing stakes and 3 trimmed.

The largest buyer was Oppenheimer & Co, adding an estimated $28.1K. The largest seller was MSD Partners, cutting an estimated $890K.

  • 12 institutional investors held Vaccinex, Inc. Common Stock (VCNX) as of Q2 2020, unchanged from Q1 2020.
  • Funds reported $4.26M of Vaccinex, Inc. Common Stock stock for Q2 2020, down 25% quarter-over-quarter.
  • 1 fund opened new Vaccinex, Inc. Common Stock positions in Q2 2020 and 1 closed out, a net change of 0 holders.
  • The largest Vaccinex, Inc. Common Stock buyer in Q2 2020 was Oppenheimer & Co, an estimated $28.1K added.
  • The largest Vaccinex, Inc. Common Stock seller in Q2 2020 was MSD Partners, an estimated $890K sold.

Based on aggregated 13F filings for Q2 2020.